GekkoVet and Royal Canin Enter Latin America with Mexico Launch, Opening a New Continent in Their Global Partnership

Why It Matters

The collaboration merges AI analytics with premium pet nutrition, raising the standard of veterinary care and opening a high‑growth digital‑health market in Latin America.

Key Takeaways

• First Latin America rollout of GekkoVet‑Royal Canin partnership
• AI platform offers real‑time diagnostics and treatment guidance
• Pilot clinics reported higher diagnostic confidence and efficiency
• Integration aligns nutrition and technology for better pet outcomes
• Expansion plans target multiple Latin American countries

Pulse Analysis

The veterinary sector is undergoing a digital transformation, with artificial intelligence emerging as a catalyst for faster, more accurate clinical decisions. Finland’s GekkoVet has positioned itself at the forefront by delivering an AI‑driven decision‑support platform that aggregates diagnostic data, drug information, and evidence‑based treatment pathways. Partnering with Royal Canin, a global nutrition specialist owned by Mars, creates a unique synergy: technology meets scientifically formulated pet food. Their joint venture, first tested in Asia, now crosses into Latin America, signaling a strategic push into emerging markets.

The Mexico rollout equips veterinary teams with GekkoVet’s real‑time diagnostic assistance, treatment recommendations, and drug reference tools, all embedded within Royal Canin’s support programs. Early adopters reported heightened diagnostic confidence and streamlined workflows, translating into shorter appointment times and more precise therapeutic choices. Educational modules tailored to the Mexican market further reinforce evidence‑based practice, while data‑driven insights enable clinics to benchmark performance against regional peers. By merging AI analytics with nutrition expertise, the collaboration promises to elevate patient outcomes and reinforce Royal Canin’s brand as a holistic pet‑health partner.

Latin America represents a fast‑growing pet care market, driven by rising disposable incomes and increasing awareness of animal welfare. The GekkoVet‑Royal Canin model offers a scalable blueprint for other countries, where limited access to advanced diagnostic tools has long constrained veterinary practice. As the partnership expands beyond Mexico, it could accelerate adoption of AI‑enabled care across the continent, creating new revenue streams for tech providers and reinforcing Royal Canin’s market penetration. Stakeholders—from clinic owners to investors—should monitor this rollout as a bellwether for digital health integration in emerging economies.